Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 581 shares at $4.89 ($3K) on 2020-12-03, disclosed to the SEC on 2020-12-07.
Tax-driven sale ($3k) by See Remarks — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.89 | 277 | $1K | 47.7% |
| 2 | $4.89 | 304 | $1K | 52.3% |
| Total | $4.89 avg | 581 | $3K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |